Q32 Bio (QTTB) closed at $8.71 on November 13, 2026, down 1.2% from the previous close, on volume of 237,230 shares (30-day average 534,843).
Data as of November 13, 2026.
13-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 13, 2026. See the 10 largest for 30, 60 and 90 days
Q32 Bio to Participate in the 2026 Jefferies Global Healthcare Conference in London
PRNewswire (Wed, 11-Nov 6:59 AM ET)
Q32 Bio Reports Third Quarter 2026 Financial Results and Provides Corporate Update
PRNewswire (Wed, 4-Nov 6:59 AM ET)
Market Chameleon (Wed, 30-Sep 5:40 AM ET)
Market Chameleon (Wed, 30-Sep 5:19 AM ET)
PRNewswire (Wed, 30-Sep 9:15 AM ET)
PRNewswire (Mon, 21-Sep 9:16 AM ET)
PRNewswire (Mon, 14-Sep 6:59 AM ET)
Q32 Bio to Participate in Upcoming September Investor Conferences
PRNewswire (Tue, 1-Sep 7:00 AM ET)
QTTB Anticipates Pivotal Clinical Data Release for Alopecia Areata as Stock Activity Surges
Market Chameleon (Mon, 13-Jul 5:51 AM ET)
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction. Its product candidate, bempikibart (ADX 914), is a fully human anti-interleukin 7 receptor alpha (IL-7R) antagonist monoclonal antibody designed to block signaling mediated by interleukin 7 (IL 7) and thymic stromal lymphopoietin (TSLP) and re-regulate adaptive immune function. The company has completed two Phase 2a clinical trials evaluating bempikibart, SIGNAL AA Part A for the treatment of alopecia areata and SIGNAL AD for the treatment of atopic dermatitis (AD).
Q32 Bio trades on the NASDAQ stock market under the symbol QTTB.
As of November 13, 2026, QTTB stock price declined to $8.71 with 237,230 million shares trading.
QTTB has a beta of -0.72, meaning it tends to be less sensitive to market movements. QTTB has a correlation of 0.01 to the broad based SPY ETF.
QTTB has a market cap of $260.64 million. This is considered a Small Cap stock.
The top ETF exchange traded funds that QTTB belongs to (by Net Assets): VTI, AVUV, VXF, FDM, DFAS.
QTTB has outperformed the market in the last year with a return of +294.1%, while the SPY ETF gained +13.4%. However, in the most recent history, QTTB shares have underperformed the stock market with its stock returning -43.3% in the last 3 month period and -2.2% for the last 2 week period, while SPY has returned -2.8% and -0.2%, respectively.
QTTB support price is $8.45 and resistance is $9.20 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that QTTB shares will trade within this expected range on the day.
